While SBS1 and SBS5 were active in both groups of mutations (pre- and post-gain), nc-AID (SBS9) was significantly enriched in the pre-gain mutations (p < 0.0001), highlighting its involvement in the earliest phase of MM pathogenesis (Fig. 5a, b). Here, AICDA is linked to Miyoshi myopathy.